COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,886 Articles (22,568 medRxiv, 8,318 bioRxiv)

Most recent first Previous |  Page 1030: Articles 10291-10300  | Next

Considerable escape of SARS-CoV-2 variant Omicron to antibody neutralization
Planas, D., Saunders, N., Maes, P., Benhassine, F. G., Planchais, C., Porrot, F., Staropoli, I., Lemoine, F., Pere, H., Veyer, D., Puech, J., Rodary, J., Bolland, W. H., Buchrieser, J., Baele, G., Dellicour, S., Raymenants, J., Gorissen, S., Geenen, C., Vanmechelen, B., Wawina, T., Marti, J., Cuypers, L., Seve, A., Hocqueloux, L., Prazuck, T., Loriere, E. S., REY, F., Bruel, T., Mouquet, H., Andre, E., Schwartz, O.
10.1101/2021.12.14.472630 — Posted: 2021-12-15
From Deer-to-Deer: SARS-CoV-2 is efficiently transmitted and presents broad tissue tropism and replication sites in white-tailed deer
Martins, M., Boggiatto, P. M., Buckley, A., Cassmann, E. D., Falkenberg, S., Caserta, L. C., Fernandes, M. H. V., Kanipe, C., Lager, K., Palmer, M. V., Diel, D. G.
10.1101/2021.12.14.472547 — Posted: 2021-12-15
Striking Antibody Evasion Manifested by the Omicron Variant of SARS-CoV-2
Liu, L., Iketani, S., Guo, Y., Chan, J. F.-W., Wang, M., Liu, L., Luo, Y., Chu, H., Huang, Y., Nair, M. S., Yu, J., Chik, K. K.-H., Yuen, T. T.-T., Yoon, C., To, K. K.-W., Chen, H., Yin, M. T., Sobieszczyk, M. E., Huang, Y., Wang, H. H., Sheng, Z., Yuen, K.-Y., Ho, D. D.
10.1101/2021.12.14.472719 — Posted: 2021-12-15
Viral infection engenders bona fide and bystander lung memory B cell subsets through permissive selection
Gregoire, C., Spinelli, L., Villazala-Merino, S., Gil, L., Moussa, M., Dong, C., Zarubica, A., Fallet, M., Navarro, J.-M., Malissen, B., Milpied, P., Gaya, M.
10.1101/2021.12.14.472614 — Posted: 2021-12-15
Long-read RNA sequencing identifies polyadenylation elongation and differential transcript usage of host transcripts during SARS-CoV-2 in vitro infection
Chang, J. J.-Y., Gleeson, J., Rawlinson, D., Pitt, M. E., De Paoli-Iseppi, R., Zhou, C., Mordant, F. L., Londrigan, S. L., Clark, M. B., Subbarao, K., Stinear, T. P., Coin, L. J. M.
10.1101/2021.12.14.472725 — Posted: 2021-12-15
Potential inhibitors for blocking the interaction of the coronavirus SARS-CoV-2 spike protein and its host cell receptor ACE2
Li, C., Zhou, H., Guo, L., Xie, D., He, H., Zhang, H., Liu, Y., Peng, L., Zheng, L., Lu, W., Mei, Y., Liu, Z., Huang, J., Wang, M., Shu, D., Ding, L., Lang, Y., Luo, F., Wang, J., Huang, B., Huang, P., Gao, S., Chen, J., Qian, C.-N.
10.1101/2021.12.14.472545 — Posted: 2021-12-15
A comprehensive examination of ACE-2 receptor and prediction of spike glycoprotein and ACE-2 interaction based on in silico analysis of ACE-2 receptor
Ozgenturk, N. O., Aktas, E.
10.1101/2021.12.14.472331 — Posted: 2021-12-15
Evidence for a mouse origin of the SARS-CoV-2 Omicron variant
Wei, C., Shan, K.-J., Wang, W., Zhang, S., Huan, Q., Qian, W.
10.1101/2021.12.14.472632 — Posted: 2021-12-15 Discussion: Onsite
Genomic determinants of Furin cleavage in diverse European SARS-related bat coronaviruses
Sander, A.-L., Moreira-Soto, A., Yordanov, S., Toplak, I., Balboni, A., Ameneiros, R. S., Corman, V. M., Drosten, C., Drexler, J. F.
10.1101/2021.12.15.472779 — Posted: 2021-12-15
Metalloproteinase-dependent and TMPRSS2-independnt cell surface entry pathway of SARS-CoV-2 requires the furin-cleavage site and the S2 domain of spike protein
Yamamoto, M., Gohda, J., Kobayashi, A., Tomita, K., Hirayama, Y., Koshikawa, N., Seiki, M., Semba, K., Akiyama, T., Kawaguchi, Y., Inoue, J.-i.
10.1101/2021.12.14.472513 — Posted: 2021-12-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).